Researchers at Leipzig University's Carl Ludwig Institute have discovered that in the cerebral cortex, synaptic signal ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

Rodent medial prefrontal cortex is not crucial for an active place avoidance task requiring cognitive control evidenced by hippocampal activity that purposefully alternates between task-relevant and ...

Cingulate raised approximately $12.5 million of capital in the third quarter of 2024. The capital raised provides the Company the cash runway to fund the clinical, manufacturing, and regulatory ...

We all have a wondrous ability to form emotional attachments to many different things, from nature and pets to romantic ...

Cingulate Inc. (NASDAQ: CING) shares are on an upward trajectory Friday. It follows the announcement that Cingulate has been granted European Patent No. 3261625 for its flagship asset, CTx-1301 ...

Cingulate secures a European patent for its ADHD treatment. The biopharma firm is committed to filing an NDA with the FDA. Cingulate stock opened about 110% up on Friday morning.

Cingulate's stock surges over 159% after being granted a European patent for its lead ADHD treatment asset, CTx-1301. CTx-1301 is designed to deliver three timed releases of medication throughout ...

The limbic system is a network of interconnected brain structures located to the side of the thalamus, which is in the center of the brain, and under the cerebral cortex, which is the wrinkly ...